BCI
PRAX icon

Brinker Capital Investments’s Praxis Precision Medicines PRAX Stock Holding History

Brinker Capital Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Sell
1,081
-653
-38% -$207K ﹤0.01% 1574
2026
Q1 		$559K Sell
1,734
-251
-13% -$77.6K ﹤0.01% 1408
2025
Q4 		$585K Buy
+1,985
New +$370K ﹤0.01% 1530

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Brinker Capital Investments's PRAX Position: Q2 2026 in Review

Brinker Capital Investments reduced its Praxis Precision Medicines (PRAX) stake by 38% in Q2 2026, selling an estimated $207K and leaving 1,081 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Brinker Capital Investments first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $585K in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Brinker Capital Investments held 1,081 shares of Praxis Precision Medicines worth $362K as of Q2 2026.
  • Brinker Capital Investments sold 653 Praxis Precision Medicines shares in Q2 2026, an estimated $207K.
  • Praxis Precision Medicines made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1574 holding.
  • Brinker Capital Investments first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • Brinker Capital Investments's Praxis Precision Medicines position peaked at $585K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.